Trial Profile
A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin With Factorial Evaluation of Irbesartan for the Prevention of Vascular Events in Patients With Atrial Fibrillation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2011
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension; Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms ACTIVE; ACTIVE-I
- Sponsors Sanofi
- 01 Sep 2009 Results were presented during a Hot Line clinical trial session at the European Society of Cardiology (ESC) meeting.
- 08 Oct 2008 Basic check conducted, added identifier and added to study centres spreadsheet; last updated 25 Sep 08.
- 25 Sep 2008 Official title added.